ATC Group: C02DB01 Dihydralazine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C02DB01 in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C02 Antihypertensives
3 C02D Arteriolar smooth muscle, agents acting on
4 C02DB Hydrazinophthalazine derivatives
5 C02DB01 Dihydralazine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
ORAL - Oral 75 mg
PAREN - Parenteral 25 mg

Active ingredients in C02DB01

Active Ingredient Description
Dihydralazine

Dihydralazine is a member of phthalazines.

Medicines in this ATC group

Brazil (BR)

France (FR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.